They may need to adapt their supply chain strategies to match the steady supply and consistency set by Glass Pharms' continuous production model to remain competitive.
This could now also bolster Cel by spurring market growth and enhancing industry standards.
Yes, I feel the same. They have great potential, especially when they've got the monopoly in this sector. The key question is, when will the prices reflect this potential?
If it goes down again. Ill buy ! I sense huge potential in this , the FDA approval process can lead to precise, high-quality cannabis-derived medications, offering a competitive edge over general dispensary products.
They could capitalise on international markets where cannabis is less accessible, broadening their revenue streams. The potential for FDA-approved drugs to command higher prices due to assured quality .
Yeah it is a half-day session ahead of the U.S. Independence Day holiday. The early market closure in the U.S. typically leads to reduced trading volumes globally